Treatment modalities for bacterial rhinosinusitis

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 5, 2010, Pages 755-769

  Brook, Itzhak ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaerobes; Antimicrobials; Haemophilus influenzae; Rhinosinusitis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CEFDINIR; CEFEPIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME AXETIL; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DECONGESTIVE AGENT; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ADJUVANT THERAPY; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGY; NONHUMAN; ORBIT INFECTION; PARANASAL SINUS; PATHOGENESIS; PENICILLIN RESISTANCE; REVIEW; RHINOSINUSITIS; RISK FACTOR; SURGICAL DRAINAGE; TOOTH INFECTION;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHRONIC DISEASE; COST OF ILLNESS; HUMANS; IMMUNOCOMPROMISED HOST; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

EID: 77949464022     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656561003598901     Document Type: Review

References (99)

1. Benninger MS, Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: summary of the Agency for Health Care Policy and Research evidence-based report. Otolaryngol Head Neck Surg 2000;122:1-7
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis initiative. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006;118(5 Suppl):17-61
3. Senior B, Glaze C, Benninger M. Use of the rhinosinusitis disability index in rhinologic disease. Am J Rhinol 2001;15:15-20
4. Clement PAR, Bluestone CD, Gordts F, et al. Management of rhinosinusitis in children. Consensus Meeting, Brussels, Belgium, 13 September 1996. Arch Otolaryngol Head Neck Surg 1998;124:31-34
5. Dunham ME. New light on sinusitis. Cont Ped 1994;1:102-117
6. Handelsman DJ, Conway AJ, Boylan LM, Turtle JR. Young's syndrome: obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med 1984;310:3-9
7. Umetsu DT, Ambrosino DM, Quinti I, et al. Recurrent sinopulmonary infections and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective igG subclass deficiency. N Engl J Med 1985;313:1247-1251
8. Berger M. Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J Pediatr 1987;110:325-328
9. Lyon E, Miller C. Current challenges in cystic fibrosis screening. Arch Pathol Lab Med 2003;127:1133-1139
10. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006;6:29-36
11. Brook I. Microbiology of acute and chronic maxillary sinusitis associated with an odontogenic origin. Laryngoscope 2005;115:823-825
12. Brook I. Aerobic and anaerobic bacteriology of purulent nasopharyngitis in children. J Clin Microbiol 1988;26:592-594
13. Savolainen S, Ylikoski J, Jousimies-Somer H. The bacterial flora of the nasal cavity in healthy young men. Rhinology 1986;24:249-255
14. Sande MA, Gwaltney JM. Acute community-acquired bacterial sinusitis-continuing challenges and current management. Clin Infect Dis 2004;39(Suppl 3):151-158
15. Brook I, Frazier EH, Foote PA. Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol 1996;45:372-375
16. Carenfelt C, Lundberg C. Purulent and non-purulent maxillary sinus secretions with respect to Po2, Pco2 and pH. Acta Otolaryngol 1977;84:138-144
17. Brook I. Role of encapsulated anaerobic bacteria in synergistic infections. Crit Rev Microbiol 1987;14:171-193
18. Brook I, Gober AE. Bacterial interference in the nasopharynx and nasal cavity of sinusitis prone and non-sinusitis prone children. Acta Otolaryngol 1999;119:832-836
19. Brook I. Bacteriologic features of chronic sinusitis in children. JAMA 1981;246:967-969
20. Brook I. Bacteriology of chronic maxillary sinusitis in adults. Ann Otol Rhinol Laryngol 1989;98:426-428
21. Brook I. Bacteriology of acute and chronic frontal sinusitis. Arch Otolaryngol Head Neck Surg 2002;128:583-585
22. Brook I. Bacteriology of acute and chronic sphenoid sinusitis. Ann Otol Rhinol Laryngol 2002;111:1002-1004
23. Brook I. Bacteriology of acute and chronic ethmoid sinusitis. J Clin Microbiol 2005;43:3479-3480
24. Brook I. Acute and chronic frontal sinusitis. Curr Opin Pulm Med 2003;9:171-174
25. Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992;90:457-462
26. Brook I, Foote PA, Hausfeld JN. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol 2006;55:943-946
27. Lew D, Southwick FS, Montgomery WW, et al. Sphenoid sinusitis. A review of 30 cases. N Engl J Med 1983;309:1149-1154
28. Brook I. Role of methicillin-resistant Staphylococcus aureus in head and neck infections. J Laryngol Otol 2009;11:1-7
29. Brook I, Frazier EH, Gher ME Jr. Microbiology of periapical abscesses and associated maxillary sinusitis. J Periodontal 1996;67:608-610
30. Shapiro ED, Milmoe GJ, Wald ER, et al. Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis 1982;146:589-593
31. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998;316:13-20
32. Bachert C, Zhang N, Patou J, et al. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 2008;8:34-38
33. Nord CE. The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis. Clin Infect Dis 1995;20:1512-1524
34. Gordts F, Halewyck S, Pierard D, et al. Microbiology of the middle meatus: a comparison between normal adults and children. J Laryngol Otol 2000;14:184-188
35. Jiang RS, Hsu CY, Jang JW. Bacteriology of the maxillary and ethmoid sinuses in chronic sinusitis. J Laryngol Otol 1998;112:845-848
36. Hsu J, Lanza DC, Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 1998;12:243-248
37. Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998;12:233-241
38. Bahattacharyya N, Kepnes LJ. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1999;125:1117-1120
39. Westrin KM, Stierna P, Carlsoo B, Hellstrom S. Mucosal fine structure in experimental sinusitis. Ann Otol Rhinol Laryngol 1993;102:639-645
40. Jyonouchi H, Sun S, Kennedy CA, et al. Localized sinus inflammation in a rabbit sinusitis model induced by Bacteroides fragilis is accompanied by rigorous immune responses. Otolaryngol Head Neck Surg 1999;120:869-875
41. Brook I, Yocum P. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1999;108:293-295
42. Aust R, Drettner B. Oxygen tension in the human maxillary sinus under normal and pathological conditions. Acta Otolaryngol (Stockh) 1974;78:264-269
43. Brook I. Brain abscess in children: microbiology and management. Child Neurol 1995;10:283-288
44. Finegold SM. Anaerobic bacteria in human disease. Academic Press, Inc., Orlando, FL; 1977
45. Brook I. Microbiology of intracranial abscesses associated with sinusitis of odontogenic origin. Ann Otol Rhinol Laryngol 2006;115:917-920
46. Erkan M, Ozcan M, Arslan S, et al. Bacteriology of antrum in children with chronic maxillary sinusitis. Scand J Infect Dis 1996;28:283-285
47. Brook I, Thompson D, Frazier E. Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1994;120:1317-1320
48. Finegold SM, Flynn MJ, Rose FV, et al. Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin Infect Dis 2002;35:428-433
49. Frederick J, Braude AI. Anaerobic infections of the paranasal sinuses. N Engl J Med 1974;290:135-137
50. Van Cauwenberge P, Verschraegen G, Van Renterghem L. Bacteriological findings in sinusitis (1963-1975). Scand J Infect Dis Suppl 1976;9:72-77
51. Karma P, Jokipii L, Sipila P, et al. Bacteria in chronic maxillary sinusitis. Arch Otolaryngol 1979;105:386-390
52. Berg O, Carenfelt C, Kronvall G. Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment. Scand J Infect Dis 1988;20:511-516
53. Fiscella RG, Chow JM. Cefixime for the teatment of maxillary sinusitis. Am J Rhinology 1991;5:193-197
54. Tabaqchali S. Anaerobic infections in the head and neck region. Scand J Infect Dis Suppl 1988;57:24-34
55. Ito K, Ito Y, Mizuta K, et al. Bacteriology of chronic otitis media, chronic sinusitis, and paranasal mucopyocele in Japan. Clin Infect Dis 1995;20(Suppl 2):214-219
56. Erkan M, Aslan T, Ozcan M, Koc N. Bacteriology of antrum in adults with chronic maxillary sinusitis. Laryngoscope 1994;104:321-324
57. Klossek JM, Dubreuil L, Richet H, et al. Bacteriology of chronic purulent secretions in chronic rhinosinusitis. J Laryngol Otol 1998;112:1162-1166
58. Brook I, Foote PA, Frazier EH. Microbiology of acute exacerbation of chronic sinusitis. Laryngoscope 2004;114:129-131
59. Brook I. Bacteriology of chronic sinusitis and acute exacerbation of chronic sinusitis. Arch Otolaryngol Head Neck Surg 2006;132:1099-1101
60. Del Borgo C, Del Forno A, Ottaviani F, et al. Sinusitis in HIV-infected patients. J Chemother 1997;9:83-88
61. Arens JF, LeJeune FE Jr, Webre DR. Maxillary sinusitis, a complication of nasotracheal intubation. Anesthesiology 1974;40:415-416
62. Brook I, Shah K. Sinusitis in neurologically impaired children. Otolaryngol Head Neck Surg 1998;119:357-360
63. Rank MA, Adolphson CR, Kita H. Antifungal therapy for chronic rhinosinusitis: the controversy persists. Curr Opin AllergyClin Immunol 2009;9:67-72
64. Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 2009;119:1809-1818
65. Talmor M, Li P, Barie PS. Acute paranasal sinusitis in critically ill patients: guidelines for prevention, diagnosis and treatment. Clin Infect Dis 1997;25:1441-1446
66. Brook I. Microbiology of nosocomial sinusitis in mechanically ventilated children. Arch Otolaryngol Head Neck Surg 1998;124:35-38
67. Godofsky EW, Zinreich J, Armstrong M, et al. Sinusitis in HIV-infected patients. A clinical and radiographic review. Am J Med 1992;93:163-170
68. Brook I, Frazier EH, Gher ME. Microbiology of periapical abscesses and associated maxillary sinusitis. J Periodontol 1996;67:608-610
69. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997;117:51-57
70. Wald ER, Guerra N, Byers C. Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991;87:129-133
71. Aalokken TM, Hagtvedt T, Dalen I, Kolbenstvedt A. Conventional sinus radiography compared with CT in the diagnosis of acute sinusitis. Dentomaxillofac Radiol 2003;32:60-62
72. Brook I. Beta-lactamase producing bacteria in head and neck infection. Laryngoscope 1988;98:428-431
73. Brook I. The role of beta-lactamase-producing bacterial in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984;6:601-607
74. Brook I, Yocum P, Frazier EH. Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1996;122:418-422
75. Brook I, Gooch WM III, Jenkins SG, et al. Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis. Ann Otol Rhinol Laryngol 2000;109:1-20
76. Brook I, Foote PA, Hausfeld JN. Increase in the frequency of recovery of meticillin-resistant Staphylococcus aureus in acute and chronic maxillary sinusitis. J Med Microbiol 2008;57:1015-1017
77. Howden BP, Johnson PD, Ward PB, et al. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006;50:3039-3047
78. Wald ER, Chiponis D, Leclesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infection in children: a double-blind, placebo-controlled trial. Pediatrics 1998;77:795-800
79. Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009;124:9-15
80. Brook I, Yocum P. Management of chronic sinusitis in children. J Laryngol Otol 1995;109:1159-1162
81. Brook I, Thompson DH, Frazier EH. Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1994;120:1317-1320
82. Lim M, Citardi MJ, Leong JL. Topical antimicrobials in management of rhinosinusitis, a systemic review. Am J Rhinol 2008;22:381-383
83. Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990;103:880-883
84. Meltzer EO, Teper A, Danzig M. Intranasal corticosteroids in the treatment of acute rhinosinusitis. Curr Allergy Asthma Rep 2008;8:133-138
85. Kalish LH, Arendts G, Sacks R, et al. Topical steroids in chronic rhinosinusitis without polyps: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2009;141:674-683
86. Joe SA, Thambi R, Huang J. A systematic review of use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008;139:340-347
87. Gross CW, Gurucharri MJ, Lazar RH, et al. Functional endoscopic sinus surgery (FESS) in the pediatric age group. Laryngoscope 1989;99:272-275
88. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992;102:1-18
89. Chandler JR, Langenbrunner DJ, Stevens EF. The pathogenesis of orbital complications in acute sinusitis. Laryngoscope 1970;80:1414-1428
90. Brook I. Microbiology of intracranial abscesses and their associated sinusitis. Arch Otolaryngol Head Neck Surg 2005;131:1017-1019
91. Brook I, Friedman E, Rodriguez WJ, Controni G. Complications of sinusitis in children. Pediatrics 1980;66:568-572
92. Baker AS. Role of anaerobic bacteria in sinusitis and its complications. Ann Otol Rhinol Laryngol Suppl 1991;154:17-22
93. Brook I, Frazier EH. Microbiology of subperiosteal orbital abscess and associated maxillary sinusitis. Laryngoscope 1996;106:1010-1013
94. Clayman GL, Adams GL, Paugh DR, et al. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope 1991;101:234-239
95. Arjmand EM, Lusk RP, Muntz HR. Pediatric sinusitis and subperiosteal orbital abscess formation: diagnosis and treatment. Otolaryngol Head Neck Surg 1993;109:886-894
96. Gerald J, Harris MD. Subperiosteal abscess of the orbit age as a factor in the bacteriology and response to treatment. Ophthalmology 1994;101:585-595
97. Dill SR, Cobbs CG, McDonald CK. Subdural empyema: analysis of 32 cases and review. Clin Infect Dis 1995;20:372-386
98. Brook I. Anaerobic osteomyelitis in children. Pediatr Infect Dis 1986;5:550-556
99. Stankiewicz JA, Newell DJ, Park AH. Complications of inflammatory diseases of the sinuses. Otolaryngol Clin North Am 1993;26:639-655